Get startedLog in
    Picture of Chemomab Therapeutics logo

    CMMB — Chemomab Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: Chemomab Awarded New U.S. Patent For Cm-101, Its First-In-Class Ccl24 Neutralizing Antibody

    Picture of Chemomab Therapeutics logoChemomab Therapeutics
    28/06/2022 12:07
    June 28 (Reuters) - Chemomab Therapeutics Ltd  CMMB.O :
    * CHEMOMAB AWARDED NEW U.S. PATENT FOR CM-101, ITS
FIRST-IN-CLASS
CCL24 NEUTRALIZING ANTIBODY

Source text for Eikon:  ID:nPn2c7vQda 
Further company coverage:  CMMB.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Chemomab Therapeutics

    See all news